Drexel's MXene Filter Materials will be used for Wearable Artificial Kidney Technology

RusНа русскомEngIn English

MXene materials Drexel University’s MXene material is one step closer to transforming the lives of people suffering from end-stage kidney disease. Nephria Bio, Inc., a U.S.-based spin-off of the South Korean medical device company EOFlow Co., Ltd., has signed a licensing agreement with the University to use the two-dimensional material, discovered at Drexel, as a filter in a wearable artificial kidney device it is developing. The technology could allow many of the millions of people suffering from end-stage kidney disease worldwide to move more freely, without spending hours each week anchored to large dialysis machines.
“Our fundamental study of titanium carbide MXene supported by NSF showed that MXene is biocompatible, able of adsorbing a variety of small molecules, and holds a lot of promise in medical applications, so it is exciting to see it applied for improving and really changing dialysis — an area of need in health care that can help millions of people,” said Yury Gogotsi, PhD, Distinguished University and Bach professor in Drexel’s College of Engineering, who is a world leader in developing and studying MXenes.
In the late stages of kidney disease, the kidneys have trouble filtering fluids and small molecules, including urea, and some of these molecules become toxic in the body when they begin to accumulate. Dialysis supports the kidneys in filtering toxins and excess fluids from the blood, but the process is time-consuming and requires patients to remain attached to immobile dialysis machines.
“This work could give hundreds of thousands of people with kidney disease the ability to live life more freely and fully,” said Meera Harhay, MD, an associate professor of Medicine in Drexel’s College of Medicine, who has been working with Gogotsi to study MXene’s application in dialysis. “A wearable artificial kidney would allow people suffering from kidney disease to more easily work and travel and maintain a more active lifestyle, which has been associated with positive health outcomes.”
A single facility-based hemodialysis session can require up to 200 liters of purified water to clear the build-up of urea and other toxic molecules from a patient’s blood. Developing a portable dialysis machine means figuring out how to reduce the amount of water the wearer would have to carry with them.
MXene is the solution, according to Jesse Kim, founding CEO of Nephria Bio and its parent company, EOFlow, because it filters urea and other electrolytes well enough that a single liter of water could be quickly cleaned and reused for the entirety of the process.
“In order to develop a wearable dialysis device, you need a material that can filter urea, which is a very, very small molecule that is also very soluble, it dissolves in water so well that it’s really hard to filter,” Kim said. “It’s the most difficult toxin to filter. And that’s why dialysis takes so long. If you go to a dialysis center, it takes 4-6 hours per session.”
MXene poresMXene is a two-dimensional material just a few atoms thick that has demonstrated a number exceptional abilities since its discovery in Drexel’s College of Engineering in 2011. Among them, the ability to filter tiny particles from liquid, which researchers in the Department Materials Science and Engineering identified several years ago, made it a prime candidate for use in dialysis.
"Two technologies are essential to develop wearable artificial kidneys; One is a small, light actuator with low power consumption, and the other is an efficient material for urea filtration. Nephria Bio secured them both—the proprietary electroosmotic pump technology from EOFlow, and the filter technology from Drexel University,” Kim said. “With the unique combination of these enabling technologies, Nephria Bio feels that it can substantially enhance dialysis therapy for kidney patients.”
Drexel researchers Gogotsi, who discovered MXenes along with fellow College of Engineering professor Michel Barsoum, PhD, and Harhay, a kidney disease specialist, have been working with Kim with support from the Coulter-Drexel Translational Research Partnership Program to combine MXene with EOFlow’s patented electrochemical actuator pump, to produce a lightweight-but-powerful filtration device that will enable portable dialysis.
The EOFlow pump is the key component of a disposable insulin patch, which recently entered the market. It launched Nephria Bio in January 2021 with the specific goal of exploring how it could be used in dialysis.
Nephria Bio’s plan is to use the pump and MXene material to produce a lightweight, highly efficient filtration system that would enable reuse and recycling of the filtration water, called dialysate. Putting the technology in a flexible, wearable, cartridge-based system, called EOPump-based Continuous Ambulatory Renal Replacement Therapy (EOCARRT™), will allow ambulatory dialysis. The system could supplement or bridge traditional dialysis therapy and, ultimately, supplant it — depending on the therapeutic needs and how the device performs, Kim said.
“Working with Nephria Bio through the Coulter program has revealed the promise of MXene materials in biomedical technology. This collaboration is taking the work of many Drexel researchers one step closer to realizing its potential as a medical application” said Kathie Jordan, PhD, director of the Coulter-Drexel program.

Source: https://drexel.edu/now/archive/2021/April/MXene-NephriaBio-wearable-artificial-kidney/





News from MRC.ORG.UA

Our new collaborative research paper with Drexel team on Porous Ti3AlC2 MAX phase enables efficient synthesis of Ti3C2Tx MXene

porous MAX phase technologyIn this study, we have optimized the synthesis of MAX phases for MXene manufacturing. The main purpose of this study is to develop a porous Ti3AlC2MAX phase that can be easily ground into individual grains manually without time-consuming eliminating the need for drilling and intenseball-milling before MXene synthesis. Moreover, we also demonstrate the synthesis of highly porous Ti3AlC2 (about 70%) from an inexpensive raw materials.

Novel electrically conductive electrospun PCL‑MXene scaffolds for cardiac tissue regeneration

Scanning electron microscopy image of PCLMXene membranes crosssection (left side) with the representation of EDX line (dotted line) and example of cross-sectional EDX elements line scan (right side)Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.

Read recently published paper about our collaborative work: MXene Functionalized Kevlar Yarn via Automated, Continuous Dip Coating

MXene Functionalized Kevlar Yarn via Automated,Continuous Dip CoatingThe rise of the Internet of Things has spurred extensive research on integrating conductive materials into textiles to turn them into sensors, antennas, energy storage devices, and heaters. MXenes, owing to their high electrical conductivity and solution processability, offer an efficient way to add conductivity and electronic functions to textiles. Here, a versatile automated yarn dip coater tailored for producing continuously high-quality MXene-coated yarns and conducted the most comprehensive MXene-yarn dip coating study to date is developed. 

MX-MAP project secondment visit of Dr. Oleksiy Gogotsi and Veronika Zahorodna from MRC to University of Padova, Italy, October 2023

altMX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 

CanbioSe Project Meeting and Project Workshop, September 26-27, 2023, Montpellier, France

altCanbioSe Project Meeting and Project Workshop was held  at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.

IEEE NAP 2023: 2023 IEEE 13th International Conference “Nanomaterials: Applications & Properties” Sep 10, 2023 - Sep 15, 2023, Bratislava, Slovakia

altDr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.

Visit to CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA)

altDirector of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.

MX-MAP Session at YUCOMAT Conference 2023 "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.

altMX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.


altThe conference was organised by the Materials Research Society of Sebia and supported by MRS-Singapore with the participation of a pleiad of distinguished scientists.

CANBIOSE secondment visit of Dr. Oleksiy Gogotsi and Veronika Zahorodna from MRC to European Institute of Membranes in Montpellier, France

altCANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.

MRC researchers visited Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to CANBIOSE project, April-May 2023

altMRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 

Twenty Third Annual Conference - YUCOMAT 2022 Twelfth World Round Table Conference on Sintering - XII WRTCS 2022 Herceg Novi, August 29 – September 2, 2022


Our collaborators and partners  presented our joint research at the Yucomat conference - at Symposium on Biomaterials and two collaborative posters at Conference Poster Session.

MRC team visited 2nd international MXene conference "MXenes: Addressing Global Challenges with Innovation"at Drexel University, USA on Aug. 1-3, 2022

second MXene COnference 2022, Drexel University, USA

MRC team members Dr. Oleksiy Gogotsi, Veronika Zahorodna, Dr. Iryna Roslyk visited MXene Confrence 2022.  This 2nd international MXene conference at Drexel University, August 1-3, 2022, put major MXene discoveries, including their record-breaking electrical conductivity, electromagnetic interference shielding capability, electrochemical capacitance, light-to-heat conversion, and other properties, into perspective.

Launching HORIZON-MSCA-2021-SE-01 MX-MAP Project: Towards MXenes biomedical applications by high-dimensional immune MAPping

MX-MAP project Meeting during the MXene international conference held in Drexel University on Aug. 3,  2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.

H2020-MSCA-RISE NANO2DAY research project, last updates


Researchers from University of Latvia and Materials Research Center, Ukraine are visiting Drexel University due to Horizon-2020-MSCA-RISE NANO2DAY research project.